Cardiology in Texas

Millar LLC is a medical sensor technology company specializing in MEMS (microelectromechanical systems) pressure sensors and related sensing solutions for medical devices and industrial applications. Founded in 1969, Millar has over 55 years of expertise in high-fidelity pressure measurement for acute and chronic monitoring. The company's core product portfolio includes acute pressure sensors (minimally invasive, high-accuracy measurement), chronic pressure sensors (TiSense implantable technology for up to 10-year monitoring in titanium housings), ISFET pH sensors, electrical conductivity (EC) sensors, oxidation-reduction potential (ORP) sensors, temperature sensors, and volume measurement solutions. Millar operates as a Contract Design and Manufacturer (CDMO) providing end-to-end sensor integration services from discovery and proof of concept through prototyping, manufacturing development, design validation, clinical trials, and device commercialization. The company holds ISO 13485 certification and operates an ISO Class 7 clean room facility supporting FDA-approved medical device production. Millar also operates a pure-play MEMS microfoundry for custom sensor fabrication. Primary markets include cardiovascular monitoring, hemodynamic pressure measurement, and OEM medical device integration. The company serves both medical device manufacturers requiring sensor integration and industrial customers requiring environmental and process monitoring solutions. Regulatory credentials include experience with FDA 510(k) pathways and clinical trial support.

Spark Biomedical Inc is a Dallas-based medical device manufacturer specializing in wearable neurostimulation solutions for complex care scenarios. The company's flagship FDA-cleared product, Sparrow Ascent, utilizes Transcutaneous Auricular Neurostimulation (tAN®) technology to deliver non-invasive, targeted bioelectronic medicine. Primary clinical applications include opioid withdrawal relief and medication reduction, with the platform expanding into neurological health, pediatrics, hemostasis, and women's health. The company conducts clinical trials and collaborates with leading healthcare organizations including the Veterans Administration, Hazelden Betty Ford Foundation, and the National Institutes of Health to advance drug-free treatment options and improve patient outcomes.

Rexmed Health is a medical device original equipment manufacturer (OEM) and contract manufacturer based in El Paso, Texas, with a manufacturing plant in Ciudad Juarez, Mexico. The company specializes in designing, engineering, and manufacturing medical devices for parenteral delivery, infusion therapy, and specialty applications. With over 20 years of experience, Rexmed manufactures products serving ophthalmic surgery, urology, parenteral nutrition, IV therapy, cardiology, airway management, and pain management sectors. Core manufacturing capabilities include fluid delivery sets, infusion pump systems, parenteral bags and configurations, and surgical dispensing coils, produced in certified clean rooms (Class 8 environment). The company holds FDA approval, COFEPRIS (Mexican regulatory) certification, CT-PAT customs certification, and operates under cGMP compliance. Rexmed provides integrated services including process validation (IQ/OQ/PQ), sterilization management, logistics and warehousing, testing services, and master validation planning. The company works with major national and multinational pharmaceutical organizations and emphasizes customized solutions, hand assembly capabilities, special testing, and small-lot production flexibility. Rexmed maintains lean enterprise methodology with six sigma practices and is recognized as a socially responsible company (ESR) by the Mexican Center for Philanthropy. Distribution and logistics partnerships include Silan Medexo (import/export), Doniphan Logistics (distribution center), and PJ Technologies (infusion pump system distribution).

CureWave Lasers manufactures high-intensity laser therapy (HILT) systems designed for non-invasive treatment of acute and chronic pain, soft tissue injuries, and difficult-to-treat orthopedic conditions. The CureWave Laser System is an infrared photobiomodulation device that operates at wavelengths exceeding 1280 nm, optimizing penetration depth while minimizing absorption by melanin, hemoglobin, and oxyhemoglobin. The system delivers photonic energy to injured and inflamed tissues, with claimed mechanisms including stimulation of cell growth, increased vascular activity, anti-inflammatory action, enhanced metabolic activity, improved nerve function, pain reduction, scar tissue reduction, and accelerated rehabilitation. Treatment sessions typically range from 15–30 minutes, with recommended initial frequency of three sessions per week adjusted based on patient progress. The device is marketed to medical practitioners, physical therapy clinics, sports medicine facilities, and athletic training centers as an alternative to pharmaceutical pain management and surgical intervention. The system is described as non-invasive with no reported adverse reactions or allergies, leveraging the body's natural healing processes. CureWave positions the technology as suitable for spinal stenosis, acute injuries, chronic pain conditions, and soft tissue healing applications. The company emphasizes clinical outcomes, practitioner return on investment, and patient satisfaction improvements. No specific FDA clearance, 510(k), ISO, or other regulatory certifications are explicitly mentioned in available content.

coVita is a leader in breath analysis and respiratory diagnostic equipment, founded in 1976 and headquartered in Santa Barbara, CA. The company manufactures FDA-cleared breath monitoring devices for clinical and occupational health applications. Their product portfolio includes: ToxCO®, a breath carbon monoxide monitor for CO poisoning detection and management; NObreath®, a FeNO (fractional exhaled nitric oxide) monitor for airway inflammation assessment in asthma diagnosis and management; Smokerlyzer® series, which measures exhaled carbon monoxide to support smoking cessation programs; and Gastrolyzer® devices for non-invasive hydrogen and methane breath testing in gastrointestinal disorder diagnosis. All primary product lines carry FDA 510(k) clearance. The company operates manufacturing and R&D facilities in Santa Barbara and maintains a USA Service Center and Customer Service & Sales Team in The Woodlands, TX. Clinical applications span pulmonology, gastroenterology, occupational health, and smoking cessation programs. Devices are designed for rapid, non-invasive patient testing in clinic and office-based settings.

MicroTransponder Inc., operating under the brand Vivistim, manufactures FDA-approved breakthrough vagus nerve stimulation (VNS) therapy systems for post-stroke upper limb recovery. The Vivistim system is a wearable neuromodulation device designed to be paired with occupational and physical therapy to enhance neuroplasticity and improve hand and arm function in chronic ischemic stroke survivors. The device delivers targeted vagal stimulation during rehabilitation exercises and daily activities, clinically demonstrated to provide 2–3 times greater improvement in upper limb function compared to intensive therapy alone. FDA-cleared as a breakthrough device for safety and efficacy, the system targets a significant market of stroke survivors with persistent upper limb impairment. The company operates a patient qualification and enrollment model, working with rehabilitation specialists and therapy centers. Clinical evidence supports high user satisfaction (98%) and lasting functional improvements with sustained reduction in impairment. The company partners with leading stroke advocacy and occupational therapy organizations, indicating strong clinical and professional credibility in the neurorehabilitation space.

Retractable Technologies, Inc. (RTI) is a publicly traded medical device manufacturer headquartered in Little Elm, Texas, specializing in safety-engineered needle products with automated retraction technology. Founded in 1994, RTI designs, manufactures, and distributes innovative solutions focused on preventing needlestick injuries and reducing bloodborne pathogen exposure in healthcare settings. The company's flagship VanishPoint® technology features automatic needle retraction activated by a single-handed, passive mechanism requiring no additional steps. RTI's comprehensive product portfolio includes safety syringes in various sizes, VanishPoint U-100 insulin syringes, EasyPoint retractable needles, blood collection devices with tube holders, and VanishPoint IV catheters. All products incorporate low dead space technology to reduce medication waste. RTI's solutions are trusted by eight of the top ten U.S. hospitals and deployed across 15,150+ healthcare facilities globally. The company emphasizes clinical safety, operational efficiency, cost reduction through medication and disposal savings, and environmental sustainability. RTI has supplied over 1.2 billion syringes for COVID-19 immunization campaigns worldwide.

Koya Medical is a medical device company founded in 2018 and headquartered in Dallas, TX, with advanced research operations in Oakland, CA. The company specializes in innovative therapeutic solutions for chronic venous and lymphatic disease management. Koya's primary product is Dayspring, a non-pneumatic compression device for lymphedema and phlebolymphedema treatment that has demonstrated superior clinical outcomes compared to pneumatic compression systems. The Dayspring platform demonstrated 4x more edema reduction and 44% higher treatment adherence versus pneumatic compression in the multi-center, randomized TEAYS trial published in the Journal of Vascular Surgery, with significant improvements in patient quality of life. The company also offers TissueIQ for lymphedema assessment, K9 for chronic venous insufficiency, and K1 for deep vein thrombosis and chronic occlusions. Koya serves healthcare professionals, patients, caregivers, and the VA/military community. The organization has treated over 14,950 patients and maintains 100+ associates. Leadership includes CEO and Founder Andy Doraiswamy, PhD (previously developed sight-restoring implants). The company provides clinical evidence-based support, professional education, reimbursement guidance, and patient support resources. Koya's mission centers on redefining vascular health through solutions addressing unmet needs across the venous and lymphatic disease continuum, with a focus on improving patient outcomes, experience, and access to care.

Insightec is a medical device manufacturer specializing in incisionless focused ultrasound technology. The company develops and markets Exablate Neuro, an MRI-guided focused ultrasound platform designed for minimally invasive neurosurgical treatment of Essential Tremor and Tremor-dominant Parkinson's Disease. The Exablate Neuro system uses acoustic energy to precisely target and ablate specific areas of the brain (thalamic nucleus) with sub-millimeter precision, guided in real-time by MRI imaging with continuous temperature monitoring. Treatment is typically performed as an outpatient procedure with immediate therapeutic effects and minimal complications. Patients generally return home the same day. The company holds FDA Pre-Market Approval (PMA P150038) for its primary indication and operates globally with headquarters in Israel, US offices in Miami and Dallas, and regional operations in Japan, China, and Europe. Insightec serves neurosurgeons, neurologists, and hospital systems internationally through direct sales and a network of distribution partners. The platform represents an alternative to traditional neurosurgical interventions, offering incision-free, precision-guided treatment with rapid patient recovery.

NeuroDynamics Global Inc manufactures and distributes an FDA-cleared Class II neuromodulation medical device for the treatment of painful diabetic neuropathy (PDN). The company's primary offering is a minimally invasive, temporary-wear neuromodulation system delivered through a 20-day in-office protocol designed to reduce chronic neuropathic pain associated with diabetes. The device represents a non-pharmacologic, non-opioid alternative to conventional pain management approaches. NeuroDynamics operates a turnkey provider program that includes comprehensive training, clinical liaison support, revenue cycle management, reimbursement navigation, and outcomes tracking tools. The therapy is positioned for multi-specialty adoption across neurology, pain management, endocrinology, and primary care settings. The company manages insurance coverage coordination and payer-specific reimbursement processes. Manufacturing and regulatory compliance meet FDA Class II standards for neuromodulation devices. The operational model emphasizes rapid practice integration, with providers able to begin treating PDN patients within weeks of program enrollment. The device is indicated for durable pain relief in diabetic neuropathy patients and is covered by many insurance plans, though coverage remains payer- and patient-specific.

Stratus Medical is a medical device manufacturer specializing in radiofrequency (RF) ablation technology for interventional pain management. The company's flagship product, the NIMBUS® RF Multitined Expandable Electrode, is designed to deliver large-volume lesions for sustained chronic pain relief across multiple anatomical targets including the lower back, neck, sacroiliac joint, shoulder, hip, and knee. The minimally invasive NIMBUS system provides predictable outcomes, faster procedure times, and enhanced cost efficiency compared to conventional RF electrodes, with pain relief typically lasting 6–12 months or longer. Stratus Medical manufactures in Magnolia, Texas and has achieved rapid growth recognition, including ranking 483 on the Deloitte Technology Fast 500™ in 2024 and inclusion on Fortune's America's Most Innovative Companies list. The company supports physician education through webinars, clinical evidence resources, and a comprehensive textbook on RF ablation techniques.

Catalyst MedTech is a leading provider of new and refurbished nuclear medicine and molecular imaging equipment, with specialized focus on PET, PET/CT, SPECT, and dedicated Brain PET systems. The company operates as a multi-vendor ecosystem partner serving OEMs, healthcare systems, imaging centers, hospitals, and specialty practices in cardiology and neurology. Core competencies include equipment sales and distribution, clinical diagnostic imaging solutions, and comprehensive service delivery through a nationwide network of service technicians. Catalyst MedTech holds ISO 13485:2016 certification covering sales, repair, refurbishment, installation, and servicing of medical imaging devices. The company positions itself as a workflow and clinical solutions partner, blending equipment, service expertise, and operational support to help practices scale operations. Target markets include nuclear medicine imaging centers, cardiology practices with advanced imaging, neurology departments, and larger healthcare systems seeking multi-vendor support and optimization. The company actively participates in industry events including FNMT, AAMI, and cardiology forums, indicating engagement with clinical imaging professionals and hospital administrators.

Berlin Heart Inc. is a US-based medical device manufacturer specializing in ventricular assist devices (VADs) for mechanical circulatory support in pediatric and adult populations. Founded in 2005 as the North American subsidiary of Berlin Heart GmbH, the company develops and markets innovative extracorporeal circulatory support systems designed to bridge pediatric and neonatal patients awaiting heart transplantation or to support recovery from acute heart failure. The flagship EXCOR® Pediatric system has demonstrated clinical reliability with use in over 2,300 pediatric patients worldwide and is FDA-approved for use across US implanting centers. Berlin Heart maintains strategic partnerships with leading cardiac centers throughout North America and provides comprehensive clinical support services including anticoagulation management, training, and outcomes documentation through the ACTION Network collaborative initiative.

Vidan Diagnostics is a B2B medical diagnostic supplier headquartered in San Antonio, Texas, specializing in laboratory diagnostic reagents and assays for critical clinical areas. The company distributes high-quality, FDA-cleared diagnostic products focused on diabetes management, sepsis biomarker detection, cardiovascular disease assessment, and anemia diagnosis. As the exclusive U.S. distributor for DiaSys Diagnostic Systems' Procalcitonin FS Assay, Vidan serves hospital laboratories and clinical diagnostic facilities with proven, easy-to-use technology platforms. The company's product portfolio emphasizes biomarker-based testing to improve patient outcomes and reduce hospital mortality, particularly in sepsis and chronic disease management.

CardioQuip is a US-based manufacturer of perfusion equipment specializing in cooler-heater devices for open-heart surgery and cardiac procedures. Originally established as a refurbisher of perfusion devices, the company leveraged extensive feedback from surgeons, biomeds, and perfusionists to design and manufacture innovative temperature control solutions. CardioQuip's flagship MCH-1000 series—including the MCH-1000(i) and MCH-1000(m) models—delivers precise patient temperature management with intuitive touchscreen interfaces, simplified cleaning protocols, and enhanced safety features. The MCH-1000(i) provides best-in-class performance with a 36L insulated tank and 1600W heating capacity, while the compact MCH-1000(m) offers full-sized performance in a space-conscious footprint. The VivaCart™ (VC-1000) provides portable transport and integration with most perfusion pumps. All equipment is designed and manufactured in the USA. CardioQuip also provides comprehensive technical support, preventive maintenance programs, and regional distribution services across North America and internationally.

Monitors.com (Bayland Technologies, Inc.) is a specialized B2B supplier of diagnostic radiology displays and PACS workstations based in Houston, Texas. With 13+ years of experience, the company sources, delivers, installs, and services medical-grade radiology monitors and complete reading stations for radiology practices, imaging centers, and hospitals worldwide. Monitors.com offers an extensive portfolio of DICOM-calibrated diagnostic displays from premium manufacturers including Barco (Nio, Coronis, Eonis), LG, and Eizo—ranging from 2MP clinical review monitors to 12MP mammography tomosynthesis displays. The company also supplies high-performance radiology workstations (Lenovo ThinkStation, HP Z-series, Dell ProMax) pre-configured with medical-grade graphics cards (Barco MXRT), and complete turnkey PACS reading stations bundled with monitors, workstations, dictation systems, and worklist displays. Monitors.com provides in-house technical support, repair, and calibration services with 48-hour turnaround, ensuring compliance with FDA and clinical standards. The company serves diagnostic radiology, mammography, general imaging, and subspecialty radiology workflows.

Wexler Surgical, Inc. is a Houston-based surgical instrumentation manufacturer specializing in high-quality specialty surgical instruments for cardiac, thoracic, vascular, and neurosurgery. Founded in 1991, the company designs and manufactures precision surgical instruments including forceps, scissors, needle holders, and specialized VATS (video-assisted thoracic surgery) and MICS (minimally invasive cardiac surgery) instruments. All products are fabricated from titanium and stainless steel to exacting specifications. The company offers customization services, instrument repair and maintenance, cross-referencing, and provides comprehensive product lines such as the Optimus Series (featuring 15-year manufacturer warranty and free maintenance), Velox double-action forceps, Viper VATS forceps, and Potts scissors with variable angle blade options. Wexler also manufactures pediatric surgical instruments and supports specialized procedures including uniport VATS and PTE (pleurectomy/decortication) operations.

Kent Imaging Inc. is a medical device company specializing in near-infrared spectroscopy (NIRS) imaging technology for wound care and tissue assessment. The company manufactures two primary portable diagnostic devices: SnapshotNIR, which non-invasively measures tissue oxygenation levels in wounds to assess perfusion and viability, and SnapshotGLO, which assesses bacterial bioburden at the bedside. These devices are designed for use in wound care management, reconstructive surgery, and clinical settings where tissue assessment is critical for treatment decisions. The SnapshotNIR device has been validated in clinical use on over 4,000 wounds and is employed to guide debridement decisions, monitor healing progression, and confirm graft viability post-operatively. SnapshotGLO addresses infection risk by enabling non-invasive bacterial assessment without invasive sampling. Together, the Snapshot Suite provides dual imaging insights to reduce diagnostic uncertainty, support earlier targeted interventions, and optimize wound healing outcomes. Kent Imaging has demonstrated 20 years of continuous innovation in NIRS medical imaging technology. The company serves wound care centers, acute care hospitals, reconstructive surgery programs, and clinical institutions requiring portable, real-time tissue assessment capabilities. Products are used in settings ranging from acute trauma management to chronic wound care optimization.

Carda Health delivers virtual cardiopulmonary rehabilitation and cardiac rehab services to patients at home. The company specializes in evidence-based clinical programs for COPD, heart failure, post-heart-attack recovery, and cardiac conditions, staffed by medical doctors, nurse practitioners, and clinical exercise physiologists (CEPs) trained at leading institutions including Mayo Clinic and Cleveland Clinic. Patients receive a home care package (tablet and monitoring devices), personalized exercise regimens, nutrition guidance, and stress management coaching. Real-time vital sign monitoring is conducted by exercise physiologists under physician supervision. The program typically spans 36 sessions over 12 weeks, with 92% of patients reporting significant improvement and 53% average gains in aerobic capacity. Carda accepts coverage from major insurers including Humana, United Healthcare, Aetna, BlueCross BlueShield, and serves members from health systems such as Intermountain, Montefiore, and Beth Israel Deaconess Medical Center. The service is positioned as more cost-effective than in-person hospital cardiac rehab (average savings of $1,200+ per program) and eliminates transportation barriers. The company holds partnerships with major health plans and integrates with telehealth platforms for remote patient engagement.

Epimed International, Inc. is a specialized medical device manufacturer founded in 1992, with facilities in Dallas, Texas and Johnstown, New York. The company designs, manufactures, and distributes high-precision needles, catheters, and related devices for interventional pain management and regional anesthesia procedures. Epimed's core focus is on acute and chronic pain treatment through minimally invasive techniques. The company's product portfolio includes Spring Guide Catheters, Racz® Catheters, radiofrequency ablation tools, cryoneuroablation systems, and specialty nerve block needles. Epimed also provides complementary services including medical training, physician education, healthcare practice consulting, and clinical education support. With ~106 employees and approximately $9.7M in annual revenue, the company emphasizes precision, safety, and risk reduction in interventional procedures, actively participating in industry conferences and workshops.

Medical Metrics, Inc. (MMI) is an independent, full-service imaging core laboratory and clinical consulting firm specializing in centralized image analysis, endpoint strategy design, and regulatory support for clinical trials and medical device development. Founded 21+ years ago, MMI serves over 260 clients and partners globally, having supported 695+ clinical trials and contributed to more than 50 FDA regulatory approvals and clearances. The company operates a science-first approach with a multidisciplinary team of biomedical engineers, medical imaging specialists, and physician reviewers who design customized imaging methodologies and protocols for device sponsors, biopharmaceutical companies, and contract research organizations. Core services include imaging endpoint strategy and scientific consulting, image review charter development, clinical site management and training, image quality and compliance monitoring, expert centralized image analysis (via independent physician readers), data interpretation, publication strategy, and post-market surveillance. MMI maintains expertise across multiple therapeutic areas including spine (fusion, motion preservation, deformity correction), orthopedics (joint arthroplasty, biologics, cartilage repair), cardiovascular (peripheral vascular disease, atherectomy, stents), neurology (stroke, aneurysm, tumor), ENT, gastrointestinal and urology, oncology, and artificial intelligence research. The firm is ISO 13485 certified and operates with emphasis on accuracy, reliability, independence, and integrity in imaging outcomes assessment.